LIFE Study: Entresto TM in Advanced Heart Failure
Brief description of study
This study aims to understand the benefits/risks of Entresto in NYHA III-IV patients.
Detailed description of study
Follow up visits include taking study drug (Entresto vs Valsartan), blood work, physical exam, questionnaires, 6 min walk tests, and medication review.Additional Information
please contact Todd Nicklas at 215-709-8747 for further questions.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Entresto,heart failure,end stage,blood pressure,heart disease,ejection fraction,cardiology,heart
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
24 Jul 2023.
Study ID: 825912